APEX1 and gastric cancer: Prx1 binds to APE1 and blocks its redox activity, inhibiting APE1/NF-κB-dependent pro-inflammatory chemokine IL-8, thereby inhibiting the migration, invasion, and metastasis of inflammation-associated cancer cells such as in gastric cancer.